spectral-ai.com - MDAI Net earnings per share for the last 12 months

Public company logo of spectral-ai.com (MDAI)

Spectral AI, Inc. (MDAI) expansion rates are constrained by clinic inertia regarding the implementation of new IT solutions and a significant reliance on government grants. Meanwhile, the real-time digital transmission of analytics to physicians optimizes the decision-making chain in emergency cases. This price chart featuring the 54.80 metric complements the overview of the business, which develops DeepView scanners for high-precision diagnosis of deep wounds within the B2B and B2G segments.

Spectral AI, Inc. - MDAI Earnings per share for the last twelve months (period 11/23/2025 - 11/12/2026)

Spectral AI - analytical breakdowns and key metrics (MDAI)

- market price and analyst price targets:
Market Chart spectral-ai.com|MDAI - Analyst Consensus Forecast
- issuer market value details:
Market Valuation Spectral AI Inc.|MDAI - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Spectral AI|MDAI - Company Book Value|Market Cap to Net Assets Ratio spectral-ai.com|MDAI - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Spectral AI, Inc.|MDAI - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Spectral AI Inc.|MDAI - Company Aggregate Debts|Debts to Net Assets Spectral AI Inc.|MDAI - Company Long-Term Debts|Company Current Liabilities Spectral AI|Quick Ratio spectral-ai.com
- financial results and valuation multiples details:
MDAI - Company Net Income|Expected Profit Spectral AI, Inc.|MDAI - Price to Earnings Ratio|Future Price to Earnings Multiple spectral-ai.com|MDAI - PEG Multiple|Company Value to EBITDA Spectral AI Inc.|MDAI - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Spectral AI|MDAI - Net earnings per share for the last 12 months|Quarterly EPS earnings growth spectral-ai.com|MDAI - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Spectral AI, Inc.
Fundamental company valuation:MDAI (spectral-ai.com)
Core merchandise of spectral-ai.com

To stress-test assets, it is critical for investors to evaluate real profitability trends, stripping away market illusions and overvaluation. By analyzing the annual change in net income per share over a rolling period, you can observe the scaling efficiency of DeepView and BARDA contracts by comparing the current TTM result with the previous year, which determines the actual monetization speed of Spectral AI, Inc. (MDAI) AI technologies.

Competitor analysis for Spectral AI, Inc.

Net earnings per share for the last four quarters abbott.com ABT|TMO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GE HealthCare Technologies Inc.|Net earnings per share for the last 12 months MTD|WAT: Earnings per share for the trailing year|Earnings per share for the last twelve months Bio-Techne Corporation (TECH)|Net earnings per share for the last 12 months bruker.com BRKR|Net earnings per share (EPS TTM) AZTA (Azenta)|Varex Imaging Corp (VREX) - Net earnings per one share for the last twelve months|Semler Scientific Corp - Net earnings per share (EPS TTM)|BFLY (Butterfly Corp) - Earnings per share for the last 12 months|MLAB: Net earnings per share (EPS TTM)|QSI - Net earnings per share for the last four quarters|NNOX (Nano-X) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Quanterix Corp. (QTRX)|Net earnings per share (EPS TTM) MASS|Net earnings per share (EPS TTM) capsovision.com (CV)|Earnings per share for the last twelve months MaxCyte, Inc. MXCT|Rapid Micro Biosystems Inc. - Earnings per share for the last twelve months|SEER: Net earnings per share for the last 12 months|Earnings per share for the trailing year HYPR (Hyperfine Inc)|FONR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Daxor (DXR)|Earnings per share for the last twelve months VivoSim Labs|ACON - Net earnings per share for the trailing year|Net earnings per share for the last 12 months AKYA (Akoya Biosciences)|Net earnings per share (EPS TTM) ThermoGenesis Holdings, Inc. (THMO)|Net earnings per share (EPS TTM) TLIS (Talis Biomedical Corporation)|Net earnings per share for the last four quarters T2 Biosystems Inc (TTOO)